MiR-182-5p Modulates Prostate Cancer Aggressive Phenotypes by Targeting EMT Associated Pathways

Prostate cancer (PCa) is a clinically heterogeneous disease, where deregulation of epigenetic events, such as miRNA expression alterations, are determinants for its development and progression. MiR-182-5p, a member of the miR-183 family, when overexpressed has been associated with PCa tumor progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Souza, Marilesia Ferreira, Cólus, Ilce Mara Syllos, Fonseca, Aline Simoneti, Antunes, Valquíria Casanova, Kumar, Deepak, Cavalli, Luciane Regina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961520/
https://www.ncbi.nlm.nih.gov/pubmed/35204688
http://dx.doi.org/10.3390/biom12020187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961520/
https://www.ncbi.nlm.nih.gov/pubmed/35204688
http://dx.doi.org/10.3390/biom12020187

Ejemplares similares